Check out the companies that make headlines before the bell. Healthequity – Health-centric FinTech Company stock plummeted 15% after quarter revenue exceeded expectations. Healthequity recorded a non-GAAP earning per share of 69 cents against revenue of $311.8 million. Analysts voted by Factset expected a profit of 72 cents per share against revenue of $355.8 million. General Mills – Shares lost more than 3% after General Mills lowered its full-year guidance and reported a topline mistake in the third quarter. Processed food companies currently believe that organic net sales are falling between 1.5% and 2% for the full year. General Mills cited inventory headwinds and soft demand as revenue of $4.844 billion in the third quarter missed Factset estimates. Goldman Sachs – Bank stocks performed from outperform as they were nearly 1% lower on the heels of Oppenheimer downgrades. Oppenheimer cited the lack of clear rebounds in mergers and acquisition activities as a key reason for Cole. GILEAD SCIENCES – Biopharmaceutical Stock slipped 2.7% after the Wall Street Journal reported that the Department of Health and Human Services was considering a plan to significantly cut federal funding for HIV prevention in the country. Gilead, which sells HIV and AIDS medications, has been sold on the news. TESLA – The electric vehicle manufacturer has made nearly 3% advance after receiving approval from the California Utilities Commission for passenger transport permits. According to a Bloomberg report, the company has applied for permission to provide ride-hale services. – Reported by CNBC’s Alex Harring and Jesse Pound
